Current treatment of dysfunctional uterine bleeding

Maturitas

Volumn 47, Issue 3, 2004, Pages 159-174

  Bongers, Marlies Y ^a   Mol, Ben W J ^b   Brölmann, Hans A M ^c  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b CPRLab   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bleeding; Dysfunctional uterine; Levonorgestrel

Indexed keywords

ANTIFIBRINOLYTIC AGENT; CONTRACEPTIVE AGENT; DANAZOL; ETAMSYLATE; GESTAGEN; GONADORELIN DERIVATIVE; LEVONORGESTREL; MEFENAMIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; SODIUM CHLORIDE; TRANEXAMIC ACID;

BLEEDING; BREAST TENDERNESS; CLINICAL TRIAL; CRYOSURGERY; DRUG EFFICACY; DRUG RELEASE; ENDOMETRIUM ABLATION; FOLLOW UP; HEALTH CARE; HIRSUTISM; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; LASER SURGERY; METRORRHAGIA; MICROWAVE RADIATION; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; QUALITATIVE ANALYSIS; QUALITY OF LIFE; REVIEW; SAFETY; SIDE EFFECT; STANDARD; SURGEON; SURGICAL INSTRUMENT; SURGICAL TECHNIQUE; TREATMENT INDICATION;

EID: 1442301728     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2003.08.002     Document Type: Article

References (124)

1. Royal College of Obstetricians and Gynaecologists. The management of menorrhagia in secondary care; 1999.
2. Vessey M.P., Villard-Mackintosh L., McPherson K., Coulter A., Yeates D. The epidemiology of hysterectomy: findings in a large cohort study. Br. J. Obstet. Gynaecol. 99:1992;402-407.
3. Luoto R., Rutanen E.M., Kaprio J. Five gynecologic diagnoses associated with hysterectomy - trends in incidence of hospitalizations in Finland, 1971-1986. Maturitas. 19:1994;141-152.
4. Luoto R., Keskimaki I., Reunanen A. Socioeconomic variations in hysterectomy: evidence from a linkage study of the Finnish hospital discharge register and population census. J. Epidemiol. Commun. Health. 51:1997;67-73.
5. Fraser I.S., MacCarron G., Markham R. A preliminary study of factors influencing perception of menstrual blood loss volume. Am. J. Obstet. Gynecol. 149:1984;788-793.
6. Chimbira T.H., Anderson A.B., Turnbull A.C. Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area. Br. J. Obstet. Gynaecol. 84:1977;763-768.
7. Gannon M.J., Day P., Hammadieh N., Johnson N. A new method for measuring menstrual blood loss and its use in screening women before eudiometrical ablation. Br. J. Obstet. Gynaecol. 103:1996;1029-1033.
8. Janssen C.A., Scholten P.C., Heintz A.P. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet. Gynecol. 85:1995;977-982.
9. Hallberg L., Hogdahl A.M., Nilsson L., Rybo G. Menstrual blood loss - a population study. Acta. Obstet. Gynecol. Scand. 45:1966;320-351.
10. Vasilenko P., Kraicer P.F., Kaplan R., deMasi A., Freed N. A new end simple method of measuring menstrual blood loss. J. Reprod. Med. 33:1988;293-297.
11. Higham J.M., O'Brien P.M.S., Shaw R.W. Assessment of menstrual blood loss using a pictorial chart. Br. J. Obstet. Gynaecol. 97:1990;734-739.
12. Deeny M., Davis J.A. Assessment of menstrual blood loss in women referred for endometrial ablation. Eur. J. Obstet. Gynecol. Reprod. Biol. 57:1994;179-180.
13. Vercellini P., Cortesi I., Oldani S., Moschetta M., De Giorgi O., Crosignani P.G. The role of transvaginal ultrasonography and outpatient diagnostic hysteroscopy in the evaluation of patients with menorrhagia. Hum. Reprod. 12:1997;1768-1771.
14. Dijkhuizen F.P.H.L.J., De Vries L.I.D., Mol B.W.J. Comparison of transvaginal ultrasonography and saline infusion sonography for the detection of intracavitary abnormalities. Ultrasound Obstet. Gynecol. 15:2000;372-376.
15. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding (Cochrane Review). The Cochrane Library, vol. 4. Oxford: Update Software; 2002.
16. Lethaby A, Augood C, Duckitt K. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding (Cochrane Review). The Cochrane Library, vol. 4. Oxford: Update Software; 2002.
17. Iyer V, Farquhar C, Jepson R. Oral contraceptive pills for heavy menstrual bleeding (Cochrane Review). The Cochrane Library, vol. 4. Oxford: Update Software; 2002.
18. Lethaby A, Irvine G, Cameron I. Cyclical progestogens for heavy menstrual bleeding (Cochrane Review). The Cochrane Library, vol. 4. Oxford: Update Software; 2002.
19. Beaumont H, Augood C, Duckitt K, Lethaby A. Danazol for heavy menstrual bleeding (Cochrane Review). The Cochrane Library, vol. 4. Oxford: Update Software; 2002.
20. Preston J.T., Cameron I.T., Adams E.J., Smith S.K. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Br. J. Obstet. Gynaecol. 102:1995;401-406.
21. Bonnar J., Sheppard B.L. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate. BMJ. 313:1996;579-582.
22. Prentice A. Medical management of menorrhagia. BMJ. 319:1999;1343-1345.
23. Fraser I.S., McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust. N.Z. J. Obstet. Gynaecol. 31:1991;66-70.
24. Higham J.M., Shaw R.W. A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia. Am. J. Obstet. Gynecol. 169:1993;1134-1139.
25. Cooper K.G., Parkin D.E., Garratt A.M., Grant A.M. A randomised comparison of medical and hysteroscopic management in women consulting a gynaecologist for treatment of heavy menstrual loss. Br. J. Obstet. Gynaecol. 104:1997;1360-1366.
26. Cooper K.G., Grant A.M., Garratt A.M. The impact of using a partially randomised patient preference design when evaluating alternative managements for heavy menstrual bleeding. Br. J. Obstet. Gynaecol. 104:1997;1367-1373.
27. Cooper K.G., Parkin D.E., Garratt A.M., Grant A.M. Two-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. Br. J. Obstet. Gynaecol. 106:1999;258-265.
28. Cooper K.G., Parkin D.E., Garratt A.M., Grant A.M. Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. Br. J. Obstet. Gynaecol. 108:2001;1222-1228.
29. Coulter A., Kelland J., Peto V., Rees M.C. Treating menorrhagia in primary care. An overview of drug trials and a survey of prescribing practice. Intern. J. Technol. Assess Health Care. 11:1995;456-471.
30. French R.S., Cowan F.M., Mansour D., Higgins J.P.T., Robinson A., Procter T.et al. Levonorgestrel-releasing (20 ug/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives. Br. J. Obstet. Gynaecol. 107:2000;1218-1225.
31. Irvine G.A., Campbell-Brown M.B., Lumsden M.A., Heikkila A., Walker J.J., Cameron I.Y. Randomised comparative study of the levonorgestrel intrauterine system and morethisterone for the treatment of idiopathic menorrhagia. Br. J. Obstet. Gynecol. 105:1998;592-598.
32. Lahteenmaki P., Haukkamaa M., Puolakka J., Sainio S., Suvisaari J. Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ. 316:1998;1122-1126.
33. Tang G.W., Lo S.S. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability. Contraception. 51:1995;231-235.
34. Crosignani P.G., Vercellini P., Mosconi P., Oldani S., Cortesi I., De Giorgi O. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in treatment of dysfunctional uterine bleeding. Obstet. Gynecol. 90:1997;257-263.
35. Lethaby AE, Cooke I, Rees M. Progesterone/progestogen releasing intrauterine systems for heavy menstrual bleeding (Cochrane Review). The Cochrane Library, vol. 4. Oxford: Update Software; 2002.
36. Istre O., Trolle B. Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Fertil. Steril. 76:2001;304-309.
37. Andersson J.K., Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br. J. Obstet. Gynaecol. 97:1990;690-694.
38. Luukkainen T., Toivonen J. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception. 52:1995;269-276.
39. Hurskainen R., Teperi J., Rissanen P., Aalto A.M., Grenman S., Kivela A.et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet. 357:2001;273-277.
40. Haynes P.J., Hodgson H., Anderson A.B., Turnbull A.C. Measurement of menstrual blood loss in patients complaining of menorrhagia. Br. J. Obstet. Gynaecol. 84:1977;763-768.
41. Ashermann J.G. Amenorrhea traumatica (atretica). Obstet. Gynecol. 55:1948;23.
42. Neuwirth R.S., Amin H.K. Excision of submucus fibroids with hysteroscopic control. Am. J. Obstet. Gynecol. 126:1976;95-99.
43. Goldrath M.H., Fuller T.A., Segal S. Laser photovaporization of the endometrium in the treatment of menorrhagia. Am. J. Obstet. Gynecol. 140:1981;14-19.
44. DeCherney A., Polan M.L. Hysteroscopic management of intrauterine lesions and intractable uterine bleeding. Obstet. Gynecol. 61:1983;392-397.
45. Vancaillie T.G. Electrocoagulation of the endometrium with the ball-end resectoscope. Obstet. Gynecol. 74:1989;425-427.
46. Lethaby A, Sheppard S, Cooke I, Farquhar C. Endometrial resection and ablation versus hysterectomy for menstrual bleeding. The Cochrane Library, vol. 4. Oxford: Update Software; 2002.
47. Garry R., Shelley-Jones D., Mooney P., Phillips G. Six hundred endometrial laser ablations. Obstet. Gynecol. 85:1995;24-29.
48. Bhattacharya S., Cameron I.M., Parkin D.E., Abramovich D.R., Mollison J., Pinion S.B.et al. A pragmatic randomised comparison of transcervical resection of the endometrium with endometrial laser ablation for the treatment of menorrhagia. Br. J. Obstet. Gynaecol. 104:1997;601-607.
49. Phillips G., Chien P.F., Garry R. Risk of hysterectomy after 1000 consecutive endometrial laser ablations. Br. J. Obstet. Gynaecol. 105:1998;897-903.
50. Baggish M.S., Sze E.H.M. Endometrial ablation: a series of 568 patients treated over an 11-year period. Am. J. Obstet. Gynecol. 174:1996;908-913.
51. Erian J. Endometrial ablation in the treatment of menorrhagia. Br. J. Obstet. Gynaecol. 101:1994;19-22.
52. Kammerer-Doak D.N., Rogers R.G. Endometrial ablation: electrocautery and laser techniques. Clin. Obstet. Gynaecol. 43:2000;561-574.
53. Tsaltas J., Taylor N., Healy M. A 6-year review of the outcome of endometrial ablation. Aust. N.Z. J. Obstet. Gynaecol. 38:1998;69-72.
54. O'Connor H., Magos A. Endometrial resection for the treatment of menorrhagia. N. Engl. J. Med. 335:1996;151-156.
55. Scottish Hysteroscopy Audit Group. A Scottish audit of hysteroscopic surgery for menorrhagia: complications and follow-up. Br J Obstet Gynaecol 1995;102:249-54.
56. Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. Br J Obstet Gynaecol 1999;106:360-6.
57. Teirney R., Arachchi G.J., Fraser I.S. Menstrual blood loss measured 5-6 years after endometrial ablation. Obstet. Gynecol. 95:2000;251-254.
58. Martyn P., Allan B. Long-term follow-up of endometrial ablation. J. Am. Assoc. Gynecol. Laparosc. 5:1998;115-118.
59. Dwyer N., Hutton J., Stirrat G.M. Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorraghia. Br. J. Obstet. Gynaecol. 100:1993;237-243.
60. Pinion S.B., Parkin D.E., Abramovich D.R.et al. Randomised trial of hysterectomy, endometrial laser ablation and transcervical resection for dysfunctional uterine bleeding. BMJ. 309:1994;979-983.
61. Gannon M.J., Holt E.M., Fairbank J., Fitzgerald M., Milne M.A., Crystal A.M.et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ. 303:1991;1362-1364.
62. Crosignani P.G., Vercellini P., Apolone G., De Giorgi O., Cortesi I., Meschia M. Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. Am. J. Obstet. Gynecol. 177:1997;95-101.
63. O'Connor H., Broadbent J.A., Magos A.L., McPherson K. Medical research council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet. 349:1997;897-901.
64. Lethaby A, Shepperd S, Cooke I, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding (Cochrane Review). The Cochrane Library, vol. 4 Oxford: Update Software; 2002.
65. Overton C., Hargreaves J., Maresh M. A national survey of the complications of endometrial destruction for menstrual disorders the MISTLETOE study. Br. J. Obstet. Gynaecol. 104:1997;1351-1359.
66. Vilos G.A., Brown S., Graham G., McCulloch S., Borg P. Genital tract electrical burns during hysteroscopic endometrial ablation: report of 13 cases in the United States and Canada. J. Am. Assoc. Gynecol. Laparosc. 7:2000;141-147.
67. Rosenberg M.K. Hyponatremic encephalopathy after rollerball endometrial ablation. Anesth. Analg. 80:1995;1046-1048.
68. Baggish M.S., Brill A.I., Rosenweig B.et al. Fatal acute glycine and sorbitol toxicity during operative hysteroscopy. J. Gynecol. Surg. 9:1993;137-142.
69. Jansen F.W., Vredevoogd C.B., van Ulzen K., Hermans J., Trimbos J.B., Trimbos-Kemper T.C. Complications of hysteroscopy: a prospective, multicenter study. Obstet. Gynecol. 96:2000;266-270.
70. Cooper J.M., Brady R.M. Late complications of operative hysteroscopy. Obstet. Gynecol. Clin. North. Am. 27:2000;367-374.
71. Mall A., Shirk G., Van Voorhis B.J. Previous tubal ligation is a risk factor for hysterectomy after rollerball endometrial ablation. Obstet. Gynecol. 100:2002;659-664.
72. Valle R.F., Baggish M.S. Endometrial carcinoma after endometrial ablation: high-risk factors predicting its occurrence. Am. J. Obstet. Gynecol. 179:1998;569-572.
73. Dijkhuizen F.P., Mol B.W.J., Brolmann H.A.M., Heintz A.P. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer. 89:2000;1765-1772.
74. Pugh C.P., Crane J.M., Hogan T.G. Successful intrauterine pregnancy after endometrial ablation. J. Am. Assoc. Gynecol. Laparosc. 7:2000;391-394.
75. Ismail M.S., Torsten U., Serour G.I., Weitzel H., Berlien H.P. Is endometrial ablation a safe contraceptive method? Pregnancy following endometrial ablation. The Eur. J. Contract. Reprod. Health Care. 3:1998;99-102.
76. Pinette M., Katz W., Drouin M., Blackstone J., Cartin A. Successful planned pregnancy following endometrial ablation with the YAG laser. Am. J. Obstet. Gynecol. 185:2001;242-243.
77. Rogerson I, Gannon, O'Donnovan P. Outcome of pregnancy following endometrial ablation. J Gynecol Surg 1994;170:1370-1.
78. Hart R., Magos A. Endometrial ablation. Cur. Opin. Obstet. Gynecol. 9:1997;226-232.
79. McCausland A.M., McCausland V.M. Depth of endometrial penetration in adenomyosis helps determine outcome of rollerball ablation. Am. J. Obstet. Gynecol. 174:1996;1786-1794.
80. Abbott J.A., Garry R. The surgical management of menorrhagia. Hum. Reprod. Update. 8:2002;68-78.
81. Overton C., Maresh M.J.A. Audit of currently available endometrial ablative techniques. Baillieres Clin. Obstet. Gynaecol. 9:1995;357-372.
82. Donnez J., Vilos G., Gannon M.J., Maheux R., Emanuel M.H., Istre O. Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a 3-year follow-up evaluation. Fertil. Steril. 75:2001;620-622.
83. Sowter MC, Lethaby A, Singla AA. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding (Cochrane Review). The Cochrane Library, vol. 4. Oxford: Update Software; 2002.
84. Lethaby A, Hickey M. Endometrial destruction techniques for heavy menstrual bleeding (Cochrane Review). The Cochrane Library, vol. 4. Oxford: Update Software; 2002.
85. Neuwirth R.S., Duran A., Singer A., MacDonald R., Bolduc L. The endometrial ablator: a new instrument. Obstet. Gynecol. 83:1994;792-796.
86. Meyer W.R., Walsh B.W., Grainger D.A., Peacock L.M., Loffer F.D., Steege J.F. Thermal balloon and rollerball ablation to treat menorrhagia: a multi-center comparison. Obstet. Gynecol. 92:1998;98-103.
87. Grainger D., Tjaden B. Thermal balloon and rollerball ablation to treat menorrhagia: two-year results from a multicenter prospective, randomized clinical trial. J. Am. Assoc. Gynecol. Laparosc. 7:2000;175-179.
88. Loffer F.D. Three-year comparison of thermal balloon and rollerball ablation in treatment of menorrhagia. J. Am. Assoc. Gynecol. Laparosc. 8:2001;48-54.
89. Loffer F.D., Grainger D. Five-year follow-up of patients participating in a randomized trial of uterine balloon therapy versus rollerball ablation for treatment of menorrhagia. J. Am. Assoc. Gynecol. Laparosc. 9:2002;429-435.
90. Bongers M.Y., Mol B.W.J., Brölmann H.A.M. Comparison of 8 versus 16 minutes heating in the treatment of menorrhagia with hot fluid balloon ablation. J. Gynecol. Surg. 15:1999;143-147.
91. Bongers M.Y., Mol B.W.J., Dijkhuizen F.P.H.L.J., Brölmann H.A.M. Is balloon-ablation as effective as endometrial electro-resection in the treatment of menorrhagia? J. Lap. Adv. Surg. Techn. 10:2000;85-92.
92. Gervaise A., Fernandez H., Capella-Allouc S., Taylor S., La Vieille S., Hamou J.et al. Thermal balloon ablation versus endometrial resection for the treatment of abnormal uterine bleeding. Hum. Reprod. 14:1999;2743-2747.
93. Amso N.N., Stabinsky S.A., McFaul P., Blanc B., Pendley L., Neuwirth R. Uterine thermal balloon therapy for the treatment of menorrhagia: the first 300 patients from a multi-center study. Br. J. Obstet. Gynaecol. 105:1998;517-523.
94. Vilos G.A., Fortin C.A., Sanders B., Pendley L., Stabinsky S.A. Clinical trial of the uterine thermal balloon for treatment of menorrhagia. J. Am. Assoc. Gynecol. Laparosc. 4:1997;559-565.
95. Romer T. The treatment of recurrent menorrhagias-Cavaterm balloon-coagulation versus rollerball-endometrial ablation - a prospective randomized comparative study. Zentrallbl Gynakol. 120:1998;511-514.
96. Hawe J.A., Phillips A.G., Chien P.F.W., Erian J., Garry R. Cavaterm thermal balloon ablation for the treatment of menorrhagia. Br. J. Obstet. Gynaecol. 106:1999;1143-1148.
97. Friberg B., Joergensen C., Ahlgren M. Endometrial thermal coagulation - degree of uterine fibrosis predicts treatment outcome. Gynecol. Obstet. Invest. 45:1998;54-57.
98. Ulmsten U., Carstensen H., Falconer C., Holm L., Lanner L., Nilsson S.et al. The safety and efficacy of MenoTreat, a new balloon device for thermal endometrial ablation. Acta. Obstet. Gynecol. Scand. 80:2001;52-57.
99. Corson S.L., Brill A.I., Brooks P.G., Cooper J.M., Indman P.D., Liu J.H.et al. Interim results of the American Vesta trial of endometrial ablation. J. Am. Assoc. Gynecol. Laparosc. 6:1999;45-49.
100. Corson S.L., Brill A.I., Brooks P.G., Cooper J.M., Indman P.D., Liu J.H.et al. One-year results of the vesta system for endometrial ablation. J. Am. Assoc. Gynecol. Laparosc. 7:2000;489-497.
101. Corson S.L. A multicenter evaluation of endometrial ablation by Hydro ThermAblator and rollerball for treatment of menorrhagia. J. Am. Assoc. Gynecol. Laparosc. 8:2001;359-367.
102. Bustos-Lopez H.H., Baggish M., Valle R.F., Vadillo-Otrega F., Ibarra V., Nava G. Assessment of the safety of intrauterine instillation of heated saline for endometrial ablation. Fertil. Steril. 69:1998;155-160.
103. Sharp N.C., Cronin N., Feldberg I., Evans M., Hodgson D., Ellis S. Microwaves for menorrhagia: a new fast technique for endometrial ablation. Lancet. 346:1995;1003-1004.
104. Cooper K.G., Bain C., Parkin D.E. Comparison of microwave endometrial ablation and transcervical resection of the endometrium for treatment of heavy menstrual loss: a randomised trial. Lancet. 354:1999;1859-1863.
105. Downes E., O'Donovan P. Microwave endometrial ablation in the management of menorrhagia: current status. Cur. Op. Obstet. Gynecol. 12:2000;293-296.
106. Bain C., Cooper K.G., Parkin D.E. Microwave endometrial ablation versus endometrial resection: a randomized controlled trial. Obstet. Gynecol. 99:2002;983-987.
107. Dobak J.D., Ryba E., Kovalcheck S. A new closed-loop cryosurgical device for endometrial ablation. J. Am. Assoc. Gynecol. Laparosc. 7:2000;245-249.
108. Dobak J.D., Willems J., Howard R., Shea C., Townsend D.E. Endometrial cryoablation with ultrasound visualization in women undergoing hysterectomy. J. Am. Assoc. Gynecol. Laparosc. 7:2000;89-93.
109. Rutherford T.J. Cryosurgery is a simple modality for endometrial ablation. J. Am. Assoc. Gynecol. Laparosc. 3:1996;S44-45.
110. Korn A.P. Endometrial cryoablation and thermal ablation. Clin. Obstet. Gynecol. 43:2000;575-583.
111. Donnez J., Polet R., Mathieu P.E., Konwitz E., Nisolle M., Casanas-Roux F. Endometrial laser interstitial hyperthermy: a potential modality for endometrial ablation. Obstet. Gynecol. 87:1996;459-464.
112. Donnez J., Polet R., Rabinovitz R., Ak M., Squifflet J., Nisolle M. Endometrial laser intrauterine thermotherapy: the first series of 100 patients observed for 1 year. Fertil. Steril. 74:2000;791-796.
113. Cooper J., Gimpelson R., Laberge P., Galen D., Garza-Leal J.G., Scott J.et al. A randomized, multicenter trial of safety and efficacy of the NovaSure System in the treatment of menorrhagia. J. Am. Assoc. Gynecol. Laparosc. 9:2002;418-428.
114. Gallinat A., Nugent W. NovaSure impedance-controlled system for endometrial ablation. J. Am. Assoc. Gynecol. Laparosc. 9:2002;283-289.
115. Carlson K.J. Outcomes of hysterectomy. Clin. Obstet. Gynecol. 40:1997;939-946.
116. Carlson K.J., Miller B.A., Fowler F.J. The main women's health study: I. Outcomes of hysterectomy. Obstet. Gynecol. 83:1994;556-565.
117. Lumsden M.A., Twaddle S., Hawthorn R., Traynor I., Gilmoe D., Davis J.et al. A randomised comparison and economic evaluation of laparoscopic-assisted hysterectomy and abdominal hysterectomy. Br. J. Obstet. Gynaecol. 107:2000;1386-1391.
118. Harris W.J., Daniell J.F. Early complications of laparoscopic hysterectomy. Obstet. Gynecol. Sur. 38:1996;559-567.
119. Harris W.J. Complications of hysterectomy. Clin. Obstet. Gynecol. 40:1997;928-938.
120. Munro M.G., Deprest J. Laparoscopic hysterectomy: does it work? A bicontinental review of the literature and clinical commentary. Clin. Obstet. Gynecol. 38:1995;401-425.
121. Mittendorf R., Aronson M.P., Berry R.E.et al. Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis. Am. J. Obstet. Gynecol. 169:1993;1119-1124.
122. Coulter A. Partnerships with patients: the pros and cons of shared clinical discision making. J. Health Serv. Res. Policy. 2:1997;112-121.
123. Gambone J.C., Reiter R.C. Hysterectomy: improving the patient's decision-making process. Clin. Obstet. Gynecol. 40:1997;868-877.
124. Nagele F., Rubinger T., Magos A. Why do women choose endometrial ablation rather than hysterectomy? Fertil. Steril. 69:1998;1063-1066.